The Relative Merits of Population-Based and Targeted Prevention Strategies

被引:76
作者
Zulman, Donna M. [1 ]
Vijan, Sandeep
Omenn, Gilbert S.
Hayward, Rodney A.
机构
[1] Univ Michigan, Robert Wood Johnson Clin Scholars Program, Ann Arbor, MI 48109 USA
基金
美国国家卫生研究院;
关键词
Risk stratification; prevention; multivariable prediction tools; cholesterol;
D O I
10.1111/j.1468-0009.2008.00534.x
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Context: Preventive medicine has historically favored reducing a risk factor by a small amount in the entire population rather than by a large amount in high-risk individuals. The use of multivariable risk prediction tools, however, may affect the relative merits of this strategy. Methods: This study uses risk factor data from the National Health and Nutrition Examination Survey III to simulate a population of more than 100 million Americans aged thirty or older with no history of CV disease. Three strategies that could affect CV events, CV mortality, and quality-adjusted life years were examined: (1) a population-based strategy that treats all individuals with a low- or moderate-intensity intervention (in which the low-intensity intervention represents a public health campaign with no demonstrable adverse effects), (2) a targeted strategy that treats individuals in the top 25 percent based on a single risk factor (LDL), and (3) a risk-targeted strategy that treats individuals in the top 25 percent based on overall CV risk (as predicted by a multivariable prediction tool). The efficiency of each strategy was compared while varying the intervention's intensity and associated adverse effects, and the accuracy of the risk prediction tool. Findings: The LDL-targeted strategy and the low-intensity population-based strategy were comparable for CV events prevented over five years (0.79 million and 0.75 million, respectively), as were the risk-targeted strategy and moderate-intensity population-based strategy (1.56 million and 1.87 million, respectively). The risk-targeted strategy, however, was more efficient than the moderate-intensity population-based strategy (number needed to treat [NNT] 19 vs. 62). Incorporating a small degree of treatment-related adverse effects greatly magnified the relative advantages of the risk-targeted approach over other strategies. Reducing the accuracy of the prediction tool only modestly decreased this greater efficiency. Conclusions: A population-based prevention strategy can be an excellent option if an intervention has almost no adverse effects. But if the intervention has even a small degree of disutility, a targeted approach using multivariable risk prediction can prevent more morbidity and mortality while treating many fewer people.
引用
收藏
页码:557 / 580
页数:24
相关论文
共 51 条
[1]   CARDIOVASCULAR-DISEASE RISK PROFILES [J].
ANDERSON, KM ;
ODELL, PM ;
WILSON, PWF ;
KANNEL, WB .
AMERICAN HEART JOURNAL, 1991, 121 (01) :293-298
[2]   Improving the prediction of coronary heart disease to aid in the management of high cholesterol levels - What a difference a decade makes [J].
Avins, AL ;
Browner, WS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 279 (06) :445-449
[3]   Using the receiver operating characteristic curve to select pretreatment and pathologic predictors for early and late postprostatectomy PSA failure [J].
Cheung, R ;
Altschuler, MD ;
D'Amico, AV ;
Malkowicz, SB ;
Wein, AJ ;
Whittington, R .
UROLOGY, 2001, 58 (03) :400-405
[4]  
Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3
[5]   Evaluating the impact of population and high-risk strategies for the primary prevention of cardiovascular disease [J].
Emberson, J ;
Whincup, P ;
Morris, R ;
Walker, M ;
Ebrahim, S .
EUROPEAN HEART JOURNAL, 2004, 25 (06) :484-491
[6]   Are the Framingham and PROCAM coronary heart disease risk functions applicable to different European populations?: The PRIME Study [J].
Empana, JP ;
Ducimetière, P ;
Arveiler, D ;
Ferrières, J ;
Evans, A ;
Ruidavets, JB ;
Haas, B ;
Yarnell, J ;
Bingham, A ;
Amouyel, P ;
Dallongeville, J .
EUROPEAN HEART JOURNAL, 2003, 24 (21) :1903-1911
[7]   Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation [J].
Ferrario, M ;
Chiodini, P ;
Chambless, LE ;
Cesana, G ;
Vanuzzo, D ;
Panico, S ;
Sega, R ;
Pilotto, L ;
Palmieri, L ;
Giampaoli, S .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2005, 34 (02) :413-421
[8]   Predicting patient outcome from acute renal failure comparing three general severity of illness scoring systems [J].
Fiaccadori, E ;
Maggiore, U ;
Lombardi, M ;
Leonardi, S ;
Rotelli, C ;
Borghetti, A .
KIDNEY INTERNATIONAL, 2000, 58 (01) :283-292
[9]   COST-EFFECTIVENESS OF WARFARIN AND ASPIRIN FOR PROPHYLAXIS OF STROKE IN PATIENTS WITH NONVALVULAR ATRIAL-FIBRILLATION [J].
GAGE, BF ;
CARDINALLI, AB ;
ALBERS, GW ;
OWENS, DK .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (23) :1839-1845
[10]   COST-EFFECTIVENESS OF HMG-COA REDUCTASE INHIBITION FOR PRIMARY AND SECONDARY PREVENTION OF CORONARY HEART-DISEASE [J].
GOLDMAN, L ;
WEINSTEIN, MC ;
GOLDMAN, PA ;
WILLIAMS, LW .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 265 (09) :1145-1151